DV
Dividend Vision

AMRX — Amneal Pharmaceuticals, Inc.

Amneal Pharmaceuticals, Inc. (AMRX)

Total return is 626.0% over the past 17.6 years, 535.5 points behind SPY at 1161.5%. Its deepest 1-year drawdown was 22.3%.

AMRX is a single-stock equity holding in the healthcare sector, specifically Amneal Pharmaceuticals, a pharmaceutical company. The fund holds no distribution rate and does not appear to pay regular dividends, making it unsuitable for income-focused investors seeking yield. This holding appeals primarily to investors seeking equity exposure to the pharmaceutical industry rather than dividend income.

AMRX key facts

Asset type
Stock
Asset class
Equity
Inception date
01/14/2009
Distribution frequency
None
Last close
$18.15
Market cap
$6,321,572,864
Average volume
2006500.0
Beta
1.255
Payout ratio
0.0
P/E ratio
37.8125
Forward P/E
6.2972
EPS
$0.48